|
WO2021069971A1
|
|
Pre-treatment tissue sensitization for focused ultrasound procedures
|
|
WO2021014221A1
|
|
Aberration corrections for dynamically changing media during ultrasound therapy
|
|
WO2020245660A1
|
|
Improved magnetic resonance (mr) performance in mr-guided ultrasound systems
|
|
WO2020217098A2
|
|
Accelerated magnetic resonance thermometry
|
|
WO2020208414A1
|
|
Systems and methods for regulating microbubbles in ultrasound procedures
|
|
WO2020128615A1
|
|
Echo-based focusing correction
|
|
WO2020109860A1
|
|
Systems and methods for correcting measurement artifacts in magnetic resonance thermometry
|
|
WO2020058757A1
|
|
Ultrasound focusing utilizing a 3d-printed skull replica
|
|
WO2020070549A1
|
|
Mems-switched ultrasonic transducer array with improved reliability
|
|
WO2020039257A1
|
|
Ultrasound-mediated neurostimulation
|
|
EP3801762A2
|
|
Improved reflection autofocusing
|
|
EP3801763A1
|
|
Focused ultrasound system with optimized monitoring of cavitation
|
|
WO2019220213A1
|
|
Adaptive sampling of k-space during mr-guided non-invasive therapy
|
|
WO2019135160A2
|
|
Multi-frequency ultrasound transducers
|
|
EP3723855A1
|
|
Controlling delivery of therapeutic agent in microbubble-enhanced ultrasound procedures
|
|
WO2019116094A1
|
|
Ultrasound focusing in dynamically changing media
|
|
CN111565642A
|
|
Phased array calibration for geometric feature and aberration correction
|
|
EP3691534A1
|
|
Frameless ultrasound therapy
|
|
CN110831665A
|
|
Cavitation enhanced targeted drug delivery and quantification
|
|
WO2018215839A2
|
|
Systems and methods for selective, targeted opening of the blood-brain barrier
|
